Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
Date:12/10/2008

ity 6,505,000 15,595,000 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $21,747,000 $23,057,000

    PEREGRINE PHARMACEUTICALS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                               THREE MONTHS ENDED         SIX MONTHS ENDED

                           October 31,  October 31,  October 31,  October 31,
                              2008        2007          2008         2007
                           Unaudited    Unaudited     Unaudited    Unaudited

    REVENUES:
    Contract manufacturing
     revenue                $983,000   $1,863,000   $2,176,000    $3,484,000
    Government contract
     revenue                 958,000            -    1,282,000             -
    License revenue                -       29,000            -        33,000
       Total revenues      1,941,000    1,892,000    3,458,000     3,517,000

    COSTS AND EXPENSES:
    Cost of contract
     manufacturing           663,000    1,402,000    1,566,000     2,583,000
    Research and
     development           4,301,000    5,100,000    8,369,000     8,724,000
    Selling, general and
     administrative        1,527,000    1,943,000    3,233,000     3,651,000

       Total costs and
        expenses           6,491,000    8,445,000   13,168,000    14,958,000

    LOSS FROM OPERATIONS  (4,550,000)  (6,553,000)  (9,710,000)  (11,441,000)

    OTHER INCOME (EXPENSE):
    Interest and other
     income                   53,000      353,000      128,000       592,000
    Interest and other
     expense                       -       (7,000)      (1,000)      (14,000)

    NET LOSS             $(4,497,000) $(6,207,000) $(9,583,000) $(10,863,000)

    weighted average
       COMMON shares
        outstanding:
        Basic and
         Diluted         226,210,617  226,210,617  226,210,617   216,141,092

      BASIC AND DILUTED

'/>"/>
SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
4. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
5. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
6. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
7. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
8. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
9. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
10. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
11. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... EnergyFirst, manufacturer of all-natural nutritional ... for its great products, thriving customer base, and ... its products as Jim’s Permalean Protein Powders and Jim’s ... EnergyFirst’s lineup of nutritional products. The Permalean brand will ... , Founded in 1999, Permalean’s products were designed to ...
(Date:7/14/2014)... Summer is the best season of the ... beach, swimming and other outdoor adventures. The promotional product experts ... and healthy all summer long. The promo product gurus at ... must-have custom imprinted products everyone must have on hand this ... sunblock. Sunscreen helps protect skin from harmful UV ...
(Date:7/14/2014)... New research and analysis from the national women's ... examines toxic ingredients in tampons, a product used by ... that may be found in the product’s absorptive materials, ... women’s health at risk. , According to WVE’s ... the potential impact of toxic chemical exposure from tampons ...
(Date:7/14/2014)... Cadeon Associates Inc. http://www.cadeon.com ... Money,” today announced that it has joined the ... helps partners resell, deploy, and develop solutions that ... TIBCO Software Inc. is a global leader in ... analytics, providing businesses the ability to capture the ...
(Date:7/13/2014)... 14, 2014 FORT LEE, N.J. – Authors ... modern approach to the science of tooth implants ... This book describes recent advances and techniques in the ... that benefit people who have lost all of their natural ... the first lower subperiosteal implant in 1940. It was ...
Breaking Medicine News(10 mins):Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 2Health News:EnergyFirst Acquires Permalean - Manufacturer of All Natural Protein Bars and Powders 3Health News:Why These Three Summer Essentials from 4AllPromos Can Improve Summer 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 2Health News:New Patent Analysis Shows Toxic Risk From Tampons 3Health News:New Patent Analysis Shows Toxic Risk From Tampons 4Health News:New Patent Analysis Shows Toxic Risk From Tampons 5Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 2Health News:Cadeon Associates Inc. Joins TIBCO Spotfire Partner Network 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 2Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 3Health News:Authors Leonard I. Linkow and Sheldon Winkler Feature Advancements in Implant Dentistry 4
... of France and of French there is always mention of that ... is just perfect with that. //But a recent tiff in the ... of salt. , The tiff rose over a report for ... cigarette packets, wine should also carry them., ,This was based ...
... now been announced that the British Government would be ... a consultant radiologist in Ireland. // ,These clinical ... scanner and have necessitated the recall of close to ... , The enquiry team will be headed by Dr ...
... to wait for more than 18 months for their treatment ... funded by Pfizer pharmaceuticals.// ,The survey found that ... their treatment in pain clinics the long wait was due ... lots of emergency patients are referred to these hospitals and ...
... Indonesian capital, Jakarta, with the country's Agriculture Minister Anton Apriyantono ... has spread all over the city.' ,The H5N1 virus ... has killed seven people., ,Indonesian health authorities and the ... the virus has spread to at least 22 of the ...
... studies have revealed the innumerable benefits of fish oil ... now shows that it might be good enough even ... associated with Multiple Sclerosis.// ,Multiple Sclerosis is ... Coping up with the disease is a significant problem ...
... and breakdown of electricity supplies, upto 90,000 senior citizens ... warned.//,As the Meteorological Office has issued its second severe ... - essential to warm homes - while some experts ... ,Charity organisations caring for the elderly warned that ...
Cached Medicine News:Health News:Bird Flu Alarm In Indonesia 2Health News:Harsh British Winter Could Kill Upto 90,000 Pensioners 2
(Date:7/11/2014)... 2014 /PRNewswire-iReach/ -- VAPETEK™, Inc. has announced a ... use in portable vaporizers, which contains CBD, or ... cannabis, cannabidiol offers consumers a THC-free product made ... vaporizer technology. Photo - http://photos.prnewswire.com/prnh/20140711/126344 ... different compounds which are currently known, two of ...
(Date:7/11/2014)... According to a new ... Material, Application (Healthcare, Homeland security, Industrial application, Nuclear ... Hand-Held Instruments, Fixed, and Installed Instruments) & Geography ... by MarketsandMarkets, the Scintillator Market is expected to ... to 2020, and reach $479.16 Million in 2020. ...
(Date:7/11/2014)... ALBANY, New York , July 11, 2014 /PRNewswire/ ... published by Transparency Market Research "Endoscopy Devices Market (Endoscopes, ... Analysis, Size, Share, Growth, Trends and Forecast, 2013-2019" the ... billion in 2012 and is expected to grow at ... reach an estimated value of USD 36.9 billion in ...
Breaking Medicine Technology:VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... Merger Agreement with Tonsun International Company Limited,... -- SHENZHEN, China, Nov. 1, 2010 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; ...
... NICOSIA, Cyprus, Nov. 1, 2010 MedWOW.com, the global online ... the addition of its newest user-oriented tool: a Medical ... difficult and costly process to look for replacement parts for ... to streamline the search for buyers unable to find the ...
Cached Medicine Technology:Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 2Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 3Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 4Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 5Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 6Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 7Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 8Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 9Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 10Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 11Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited 12MedWOW Adds Parts Finder Service and Enhances Business Model 2
The major innovations in posterior stabilized (PS) knee design....
Profix total knee system is intended for cemented use only....
... The Scorpio Knee's single axis ... rotation deeper to the posterior ... the patello-femoral moment arm. Quadriceps ... to provide greater leverage and ...
... Maxim knee system's curved-on-curved articulation maintains ... excellent sizing options for better patient ... alloy plasma spray porous coating, which ... own ArCom processed polyethylene is used ...
Medicine Products: